Correlation Between FibroGen and Barclays PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroGen and Barclays PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and Barclays PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroGen and Barclays PLC, you can compare the effects of market volatilities on FibroGen and Barclays PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of Barclays PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and Barclays PLC.

Diversification Opportunities for FibroGen and Barclays PLC

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between FibroGen and Barclays is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and Barclays PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barclays PLC and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with Barclays PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barclays PLC has no effect on the direction of FibroGen i.e., FibroGen and Barclays PLC go up and down completely randomly.

Pair Corralation between FibroGen and Barclays PLC

Assuming the 90 days trading horizon FibroGen is expected to generate 1.19 times less return on investment than Barclays PLC. In addition to that, FibroGen is 4.35 times more volatile than Barclays PLC. It trades about 0.03 of its total potential returns per unit of risk. Barclays PLC is currently generating about 0.15 per unit of volatility. If you would invest  13,014  in Barclays PLC on November 9, 2024 and sell it today you would earn a total of  17,486  from holding Barclays PLC or generate 134.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

FibroGen  vs.  Barclays PLC

 Performance 
       Timeline  
FibroGen 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, FibroGen showed solid returns over the last few months and may actually be approaching a breakup point.
Barclays PLC 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Barclays PLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Barclays PLC showed solid returns over the last few months and may actually be approaching a breakup point.

FibroGen and Barclays PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroGen and Barclays PLC

The main advantage of trading using opposite FibroGen and Barclays PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, Barclays PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barclays PLC will offset losses from the drop in Barclays PLC's long position.
The idea behind FibroGen and Barclays PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency